Substance / Medication

Doxazosin

Overview

Active Ingredient
doxazosin
RxNorm CUI
49276

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Clinical Trials

4 trials linked to this intervention

4
Total Trials
1
Recruiting
2
With Results

Research Evidence

Published studies and systematic reviews

Sort:
The safety and efficacy of doxazosin in medical expulsion therapy for distal ureteric calculi: A meta-analysis.
Yu Baozhong, Zheng Xiang, Sun Zejia et al. · PLoS One · 2021
PMID: 33493214Meta-AnalysisFull text (PMC)
Effects of MDMA alone and after pretreatment with reboxetine, duloxetine, clonidine, carvedilol, and doxazosin on pupillary light reflex.
Hysek Cédric M, Liechti Matthias E · Psychopharmacology (Berl) · 2012
PMID: 22700038Meta-Analysis
Beneficial effects of extended-release doxazosin and doxazosin standard on sexual health.
Kaplan Steven A, DE Rose Aldo F, Kirby Roger S et al. · BJU Int · 2006
PMID: 16469026Meta-Analysis
A Double-Blind Randomized Controlled Trial of Doxazosin for Co-Occurring PTSD and Alcohol Use Disorder in Veterans.
Back Sudie E, Flanagan Julianne C, Mintz Jim et al. · J Clin Psychiatry · 2023
PMID: 36883885RCT
Pharmacogenetics of Dopamine β-Hydroxylase in cocaine dependence therapy with doxazosin.
Zhang Xuefeng, Nielsen David A, Domingo Coreen B et al. · Addict Biol · 2019
PMID: 29498170RCTFull text (PMC)
A preliminary investigation into the effects of doxazosin on cognitive functioning in tobacco-deprived and -satiated smokers.
Roberts Walter, Verplaetse Terril L, Moore Kelly E et al. · Hum Psychopharmacol · 2018
PMID: 29878501RCTFull text (PMC)
Higher pretreatment blood pressure is associated with greater alcohol drinking reduction in alcohol-dependent individuals treated with doxazosin.
Haass-Koffler Carolina L, Goodyear Kimberly, Zywiak William H et al. · Drug Alcohol Depend · 2017
PMID: 28551590RCTFull text (PMC)

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Health Goals

Goals connected through associated conditions

Quick Facts

Type
Substance / Medication
Fully Specified Name
Doxazosin (substance)
SNOMED CT
372508002
UMLS CUI
C0114873
RxNorm CUI
49276

Clinical Data

This intervention maps to 8 entities in the Healos knowledge graph.

4
Conditions
1
Biomarkers
2
Specialists
0
Symptoms
4
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.